20:02 EDT Cathie Wood’s ARK Investment bought 140K shares of Nurix Therapeutics today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NRIX:
- Nurix Therapeutics price target lowered to $24 from $31 at Baird
- Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update
- Nurix Therapeutics price target raised to $35 from $33 at H.C. Wainwright
- Cathie Wood’s ARK Investment bought 341.3K shares of Nurix Therapeutics today
- Nurix Therapeutics partners with Seagen to develop cancer therapeutics